Table 1.
Change Versus Baseline at 12 Months | ||
---|---|---|
Placebo (kg) | MK-0677 (kg) | |
FFM | −0.5 (CI, −1.1 to 0.2) | 1.1 (CI, 0.7 to 1.5)*** |
Total appendicular FFM | −0.3 (CI, −0.6 to 0.1) | 0.5 (CI, 0.3 to 0.8)*** |
Increase total appendicular fat on MK-0677 versus placebo | 0.24 | 1.1** |
Body weight | 0.8 (CI, −0.3 to 1.8) | 2.7 (CI, 2.0 to 3.5)* |
Notes: GH 24-h mean GH increased 1.8-fold (CI, 1.56- to 2.0-fold) from baseline (p < .001). IGF-1 Serum IGF-I levels also increased by 1.5-fold (CI, 1.4- to 1.6-fold; p < .001). FFM = fat-free mass; GH = growth hormone; IGF-1 = insulin-like growth factor.
*** p < .001.
** p = .001.
*p = .003.